ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Cavendish Biotechnology Ltd

Cavendish Biotechnology Ltd is an active company incorporated on 14 November 2019 with the registered office located in Oxford, Oxfordshire. Cavendish Biotechnology Ltd was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12316036
Private limited company
Age
5 years
Incorporated 14 November 2019
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 13 November 2024 (10 months ago)
Next confirmation dated 13 November 2025
Due by 27 November 2025 (2 months remaining)
Last change occurred 1 year 10 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 March 2025
Due by 31 December 2025 (3 months remaining)
Contact
Address
C/O Gravita Oxford Llp First Floor, Park Central
40/41 Park End Street
Oxford
OX1 1JD
United Kingdom
Address changed on 28 Oct 2024 (10 months ago)
Previous address was C/O Critchleys Llp Beaver House 23-38 Hythe Bridge Street Oxford Oxfordshire OX1 2EP United Kingdom
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
1
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in England • Born in Nov 1956
Cavendish Biotec Group Management Ltd
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Cavendish Biotec Group Management Ltd
Kevin John Norville is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Mar 2024
For period 31 Mar31 Mar 2024
Traded for 12 months
Cash in Bank
£106
Decreased by £11 (-9%)
Turnover
Unreported
Same as previous period
Employees
1
Same as previous period
Total Assets
£657
Decreased by £56 (-8%)
Total Liabilities
-£47.86K
Increased by £11.68K (+32%)
Net Assets
-£47.21K
Decreased by £11.73K (+33%)
Debt Ratio (%)
7285%
Increased by 2209.63% (+44%)
Latest Activity
Confirmation Submitted
10 Months Ago on 13 Nov 2024
Registered Address Changed
10 Months Ago on 28 Oct 2024
Cavendish Biotec Group Management Ltd (PSC) Details Changed
10 Months Ago on 25 Oct 2024
Full Accounts Submitted
1 Year 2 Months Ago on 3 Jul 2024
Mr Kevin John Norville Details Changed
1 Year 5 Months Ago on 27 Mar 2024
Confirmation Submitted
1 Year 10 Months Ago on 13 Nov 2023
Full Accounts Submitted
1 Year 10 Months Ago on 18 Oct 2023
Kevin Norville (PSC) Resigned
2 Years 5 Months Ago on 3 Apr 2023
Cavendish Biotec Group Management Ltd (PSC) Appointed
2 Years 5 Months Ago on 3 Apr 2023
Mr Kevin Norville (PSC) Details Changed
2 Years 8 Months Ago on 1 Jan 2023
Get Credit Report
Discover Cavendish Biotechnology Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 13 November 2024 with no updates
Submitted on 13 Nov 2024
Registered office address changed from C/O Critchleys Llp Beaver House 23-38 Hythe Bridge Street Oxford Oxfordshire OX1 2EP United Kingdom to C/O Gravita Oxford Llp First Floor, Park Central 40/41 Park End Street Oxford OX1 1JD on 28 October 2024
Submitted on 28 Oct 2024
Change of details for Cavendish Biotec Group Management Ltd as a person with significant control on 25 October 2024
Submitted on 28 Oct 2024
Total exemption full accounts made up to 31 March 2024
Submitted on 3 Jul 2024
Director's details changed for Mr Kevin John Norville on 27 March 2024
Submitted on 11 Apr 2024
Confirmation statement made on 13 November 2023 with updates
Submitted on 13 Nov 2023
Total exemption full accounts made up to 31 March 2023
Submitted on 18 Oct 2023
Notification of Cavendish Biotec Group Management Ltd as a person with significant control on 3 April 2023
Submitted on 25 Aug 2023
Cessation of Kevin Norville as a person with significant control on 3 April 2023
Submitted on 25 Aug 2023
Resolutions
Submitted on 29 Mar 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year